88 research outputs found

    Emergent Comorbid Events in First Year of Immunomodulatory Treatment in Adults With Generalized Myasthenia Gravis treated in a Neurology Clinic: A Retrospective Review

    Get PDF
    Background: Current treatments for myasthenia gravis, including immunomodulatory therapies, are associated with significant comorbid events. Method: Retrospective chart review of all adults diagnosed with generalized myasthenia gravis in our clinic over 5 years to evaluate potential associations between treatment regimens and emergent comorbid events according to system organ class. Comorbid events were categorized by affected system organ class as endocrine, neuropsychiatric, musculoskeletal, gastrointestinal, pulmonary, cardiovascular, urologic, infectious, and hematologic. MG treatment regimens at the latest available date during the 1-year follow-up were categorized by corticosteroid use and further stratified by medication class and combination therapy. Result: A total of 68 patients were included in the analysis (corticosteroid group, n = 43; non-corticosteroid group, n = 25). We found no significant differences in the frequencies of comorbid events between patients whose regimens included corticosteroids and patients with corticosteroid-free regimens. Patients who received pyridostigmine, high-dose corticosteroids, and corticosteroid-sparing agents in combination experienced higher incidences of emergent endocrine and neuropsychiatric events than those who received other corticosteroid-containing treatments. Conclusion: Polypharmacy that included high-dose corticosteroids was associated with a greater incidence of new endocrine and neuropsychiatric comorbid events within 1 year of diagnosi

    Emergent Comorbid Events in First Year of Immunomodulatory Treatment in Adults With Generalized Myasthenia Gravis treated in a Neurology Clinic: A Retrospective Review

    Get PDF
    Background: Current treatments for myasthenia gravis, including immunomodulatory therapies, are associated with significant comorbid events. Method: Retrospective chart review of all adults diagnosed with generalized myasthenia gravis in our clinic over 5 years to evaluate potential associations between treatment regimens and emergent comorbid events according to system organ class. Comorbid events were categorized by affected system organ class as endocrine, neuropsychiatric, musculoskeletal, gastrointestinal, pulmonary, cardiovascular, urologic, infectious, and hematologic. MG treatment regimens at the latest available date during the 1-year follow-up were categorized by corticosteroid use and further stratified by medication class and combination therapy. Result: A total of 68 patients were included in the analysis (corticosteroid group, n = 43; non-corticosteroid group, n = 25). We found no significant differences in the frequencies of comorbid events between patients whose regimens included corticosteroids and patients with corticosteroid-free regimens. Patients who received pyridostigmine, high-dose corticosteroids, and corticosteroid-sparing agents in combination experienced higher incidences of emergent endocrine and neuropsychiatric events than those who received other corticosteroid-containing treatments. Conclusion: Polypharmacy that included high-dose corticosteroids was associated with a greater incidence of new endocrine and neuropsychiatric comorbid events within 1 year of diagnosi

    BIOMECHANICAL ANALYSIS OF LOADED PLYOMETRIC EXERCISES

    Get PDF
    Plyometric intensity and specificity are determined by the exercises performed. This study assessed ground reaction forces (GRF) in the frontal (F), horizontal-anterior (H), and vertical (V) planes, and the ratio of H to V GRF (H:V) of plyometric exercises and load conditions. Subjects (N=15) performed five plyometric variations with five handheld loads on two force platforms. A two-way RM ANOVA was used. Analysis of F GRF revealed main effects for plyometric exercise (p = 0.004). Analysis of H GRF revealed main effects for plyometric load (p = .042) and plyometric exercise (p ≤ 0.001). Analysis of V GRF revealed main effects for plyometric load (p ≤ 0.001) and plyometric exercise (p ≤ 0.001). Analysis of H:V revealed main effects for plyometric exercise (p ≤ 0.001). Practitioners should use the plyometric exercises and loads that optimize the kinetics and transfer of training

    BIOMECHANICAL ANALYSIS OF ACCELERATION LADDERS WITH VARYING STEP DISTANCES

    Get PDF
    This study assessed select kinetics and kinematics of each of the first three steps of the acceleration phase of sprinting using three different acceleration ladders. Subjects (N=15) performed sprints using acceleration ladders with short, medium, and long rung spacing, over two large force platforms. Multi-factorial repeated measure ANOVAs were used to assess horizontal and vertical ground reaction force (GRF), the ratio of horizontal to vertical GRF, the duration of vertical GRF, time between steps, distance between steps, and velocity between steps and across all steps. Main effects were significant (p ≤ 0.05) for all variables except time. Post-hoc analysis identified a variety of differences in the dependent variables in the analysis of steps, test condition and their interaction (p ≤ 0.05). Results show that greater velocity is attained with ladders that have longer step distances

    Effect of the dietary supplement Meltdown on catecholamine secretion, markers of lipolysis, and metabolic rate in men and women: a randomized, placebo controlled, cross-over study

    Get PDF
    <p>Abstract</p> <p>Background</p> <p>We have recently reported that the dietary supplement Meltdown<sup>® </sup>increases plasma norepinephrine (NE), epinephrine (EPI), glycerol, free fatty acids (FFA), and metabolic rate in men. However, in that investigation measurements ceased at 90 minutes post ingestion, with values for blood borne variables peaking at this time. It was the purpose of the present investigation to extend the time course of measurement to 6 hours, and to include women within the design to determine if sex differences to treatment exist.</p> <p>Methods</p> <p>Ten men (24 ± 4 yrs) and 10 women (22 ± 2 yrs) ingested Meltdown<sup>® </sup>or a placebo, using a randomized, cross-over design with one week separating conditions. Blood samples were collected immediately before supplementation and at one hour intervals through 6 hours post ingestion. A standard meal was provided after the hour 3 collection. Samples were assayed for EPI, NE, glycerol, and FFA. Five minute breath samples were collected at each time for measurement of metabolic rate and substrate utilization. Area under the curve (AUC) was calculated. Heart rate and blood pressure were recorded at all times. Data were also analyzed using a 2 (sex) × 2 (condition) × 7 (time) repeated measures analysis of variance, with Tukey <it>post hoc </it>testing.</p> <p>Results</p> <p>No sex × condition interactions were noted for AUC for any variable (p > 0.05). Hence, AUC data are collapsed across men and women. AUC was greater for Meltdown<sup>® </sup>compared to placebo for EPI (367 ± 58 pg·mL<sup>-1</sup>·6 hr<sup>-1 </sup>vs. 183 ± 27 pg·mL<sup>-1</sup>·6 hr<sup>-1</sup>; p = 0.01), NE (2345 ± 205 pg·mL<sup>-1</sup>·6 hr<sup>-1 </sup>vs. 1659 ± 184 pg·mL<sup>-1</sup>·6 hr<sup>-1</sup>; p = 0.02), glycerol (79 ± 8 μg·mL<sup>-1</sup>·6 hr<sup>-1 </sup>vs. 59 ± 6 μg·mL<sup>-1</sup>·6 hr<sup>-1</sup>; p = 0.03), FFA (2.46 ± 0.64 mmol·L<sup>-1</sup>·6 hr<sup>-1 </sup>vs. 1.57 ± 0.42 mmol·L<sup>-1</sup>·6 hr<sup>-1</sup>; p = 0.05), and kilocalorie expenditure (439 ± 26 kcal·6 hrs<sup>-1 </sup>vs. 380 ± 14 kcal·6 hrs<sup>-1</sup>; p = 0.02). No effect was noted for substrate utilization (p = 0.39). Both systolic and diastolic blood pressure (p < 0.0001; 1–16 mmHg), as well as heart rate (p = 0.01; 1–9 bpm) were higher for Meltdown<sup>®</sup>. No sex × condition × time interactions were noted for any variable (p > 0.05).</p> <p>Conclusion</p> <p>Ingestion of Meltdown<sup>® </sup>results in an increase in catecholamine secretion, lipolysis, and metabolic rate in young men and women, with a similar response for both sexes. Meltdown<sup>® </sup>may prove to be an effective intervention strategy for fat loss, assuming individuals are normotensive and their treatment is monitored by a qualified health care professional.</p

    Complex 3-Dimensional Microscale Structures for Quantum Sensing Applications

    Full text link
    We present a novel method for fabricating highly customizable three-dimensional structures hosting quantum sensors based on Nitrogen Vacancy (NV) centers using two-photon polymerization. This approach overcomes challenges associated with structuring traditional single-crystal quantum sensing platforms and enables the creation of complex, fully three-dimensional, sensor assemblies with sub-microscale resolutions (down to 400 nm) and large fields of view (>1 mm). By embedding NV center-containing nanoparticles in exemplary structures, we demonstrate high sensitivity optical sensing of temperature and magnetic fields at the microscale. Our work showcases the potential for integrating quantum sensors with advanced manufacturing techniques, facilitating the incorporation of sensors into existing microfluidic and electronic platforms, and opening new avenues for widespread utilization of quantum sensors in various applications

    The Water Cycle from Space: Use of Satellite Data in Land Surface Hydrology and Water Resource Management

    Get PDF
    This slide presentation reviews how our understanding of the water cycle is enhanced by our use of satellite data, and how this informs land surface hydrology and water resource management. It reviews how NASA's current and future satellite missions will provide Earth system data of unprecedented breadth, accuracy and utility for hydrologic analysis
    • …
    corecore